April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Inhibition of Retinal Protection by AL-8309B, A 5-HT1A AGONIST, With WAY 100635, a 5-HT1A Antagonist, in the Rat Photo-Oxidative Injury Model
Author Affiliations & Notes
  • R. J. Collier
    Retina Drug Discovery,
    Alcon Research Ltd, Fort Worth, Texas
  • O. Dembinska
    Degenerative Diseases,
    Alcon Research Ltd, Fort Worth, Texas
  • C. Cully-Adams
    Retina Drug Discovery,
    Alcon Research Ltd, Fort Worth, Texas
  • E. Martin
    Retina Drug Discovery,
    Alcon Research Ltd, Fort Worth, Texas
  • H. Hoang
    Retina Drug Discovery,
    Alcon Research Ltd, Fort Worth, Texas
  • C. Romano
    Retina Discovery Rsch, Alcon Laboratories, Inc, Fort Worth, Texas
  • Footnotes
    Commercial Relationships  R.J. Collier, Alcon Research, Ltd, E; O. Dembinska, Alcon Research, Ltd, E; C. Cully-Adams, Alcon Research, Ltd, E; E. Martin, Alcon Research, Ltd, E; H. Hoang, Alcon Research, Ltd, E; C. Romano, Alcon Research, Ltd, E.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 3327. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R. J. Collier, O. Dembinska, C. Cully-Adams, E. Martin, H. Hoang, C. Romano; Inhibition of Retinal Protection by AL-8309B, A 5-HT1A AGONIST, With WAY 100635, a 5-HT1A Antagonist, in the Rat Photo-Oxidative Injury Model. Invest. Ophthalmol. Vis. Sci. 2010;51(13):3327.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Exposure of rats to blue light results in significant retinal lesions. The 5-HT1A agonists, AL-8309B and 8-OH DPAT completely ameliorated these lesions. The goal of this experiment was to determine if the retinoprotective activity measured with 5-HT1A agonists requires activation of the 5-HT1A receptor. This was determined by pre-dosing rats with a 5-HT1A antagonist, WAY 100635, prior to dosing with AL-8309B or 8-OH DPAT.

Methods: : To determine the dose that protected retinal function by 50% to be used in the 5-HT1A agonist/ antagonist experiment, albino rats were dosed once with vehicle, 8-OH DPAT (0.05 - 0.5 mg/kg) or AL-8309B (0.1-30 mg/kg) SQ immediately prior to a 6-hr blue-light exposure. Photo-oxidative induced lesions were generated by exposure to blue light (3.1 X 103 mW/cm2). ERGs were measured to assess retinal function 5 days after light exposure. In the 5-HT1A agonist/antagonist experiment, rats were dosed with vehicle, 5-HT1A agonist, 5-HT1A agonist + Way 100635, or WAY 100635. Rats were dosed once with WAY 100635 thirty minutes before light exposure and/or were dosed with 5-HT1A agonist once immediately before light exposure began.

Results: : Five days after light exposure, ERG a- and b-wave responses from vehicle-dosed light-exposed rats were significantly (p<0.05) depressed compared to controls. ERGs recorded from rats dosed once with 8-OH DPAT (0.1 - 0.5 mg/kg) or AL-8309B (1- 30 mg/kg) were significantly protected (p<0.05) from this photo-oxidative induced retinopathy. Protection provided by dosing with 8-OH DPAT (0.5 mg/kg) was inhibited in rats predosed with the 5-HT1A antagonist, WAY 100635 (0.5 and 5 mg/kg). ERGs recorded from rats dosed once with WAY 100635 (5 mg/kg) 30 minutes prior to dosing with 8-OH DPAT and light exposure were not significantly (p>0.05) higher than ERG responses from vehicle-dosed rats. Similarly, protection provided by dosing with AL-8309B (1 mg/kg) was significantly inhibited in rats predosed with WAY 100635 (1 and 10 mg/kg).

Conclusions: : ERGs recorded from rats dosed once with AL-8309B or 8-OH DPAT immediately before light exposure were significantly protected (p<0.05) from photo-oxidative induced retinopathy. This indicates that the mechanism of protection is activated quickly in this model. This protection was inhibited by treatment with a 5-HT1A antagonist, WAY 100635, demonstrating the requirement of activating the 5-HT1A receptor in initiating this survival pathway.

Keywords: radiation damage: light/UV • oxidation/oxidative or free radical damage • neuroprotection 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×